Neurobiology of Opioid Dependence: 5 - 5

Yale University logo

Yale University

Status and phase

Withdrawn
Phase 2

Conditions

Opioid-Related Disorders

Treatments

Drug: Naltrexone

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000196
NIDA-00191-5
K20-00191-5
K20DA000191 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to determine the effect of acute naltrexone pretreatment on the response to yohimbine in healthy volunteers.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems